News | March 18, 2024
AstraZeneca to acquire Amolyt Pharma
Acquisition to further expand the Alexion, AstraZeneca Rare Disease pipeline beyond complement inhibition
Acquisition to further expand the Alexion, AstraZeneca Rare Disease pipeline beyond complement inhibition
Strategic multi-year research collaboration to identify novel targets with strong disease links and to accelerate clinical development
This partnership marks a significant step for the Company towards establishing renewable energy power generation using hybrid open excess through solar and wind sources
PREVENAR offers the broadest serotype coverage of any pediatric pneumococcal conjugate vaccine to help protect infants and children from the 20 serotypes responsible for the majority of currently circulating pneumococcal disease in the EU and globally
AbCellera will receive an upfront payment and is eligible to receive additional milestone payments
Arun is currently working as Vice President (Strategy) in Solara leading Business finance & Strategy function
The investment will catalyse various components of the IndiaAI Mission
Group sales came in at 47.637 billion euros, down 1.2% on a currency- and portfolio-adjusted basis
The National One Health Mission will help India to achieve integrated disease control and pandemic preparedness
Survodutide has potential to become best-in-class treatment for metabolic dysfunction-associated steatohepatitis
Subscribe To Our Newsletter & Stay Updated
